Here’s a preview of the featured content to watch for this week on Drug Topics®.
Coronavirus Research News
With an estimated 231 million COVID-19 vaccine doses administered and 569,000 COVID-19–associated deaths in the US as of this article’s press time, keeping up with pandemic news is more important than ever. Check back to Drug Topics® to stay informed on the latest coronavirus-related news and research.
Read more coronavirus-related news.
The Latest from Total Pharmacy®: Considerations for Starting a Specialty Pharmacy: Part 2
In this article, Molly C. Gombos, PharmD, MPBA Candidate, takes a closer look at accreditation, using technology and data, and licensure and payer contracts for specialty pharmacies.
Read more on totalpharmacy.com.
Drug Topics® Journal, May 2021 Digital Edition
The May 2021 digital edition of Drug Topics Journal will soon be available on DrugTopics.com. In our upcoming issue, Drug Topics® covers the latest in diabetes, vaccines, health systems and more, and our cover story highlights the emerging roles in mental health care for pharmacists.
Medical World News Updates
In an interview with Drug Topics®, Scott Caravello, owner of Galva Pharmacy in Illinois and Cam Deemer, president of DrFirst will be discussing the significance of DrFirst’s SmartSuite artificial intelligence (AI) tool and how it can help free up valuable time for independent pharmacists.
Understanding Specialty Pharmacy (Part 3): Intersections With Retail
The last part of our article series on understanding the specialty pharmacy landscape will focus on the intersections with retail pharmacy. Check back to drugtopics.com on Friday, April 30, to read the article.
Now On Demand: Use the Right Analytics to Unlock Value Beyond Prescription Reimbursements
Watch this webinar on demand to learn how your pharmacy can accelerate its growth strategy by applying data and analytics that identify referral patterns and reimbursements for services rendered.
Watch it here.
In Case You Missed It: ACIP Recommends Resuming Use of Johnson & Johnson COVID-19 Vaccine
A committee of vaccine advisers to the CDC convened to discuss the risk of a rare blood clotting condition linked to the Johnson & Johnson COVID-19 vaccine.